A study in The European Journal of Public Health finds conversation on preventive vaccination against HPV can motivate participation in preventive screening for cervical cancer.
A vaccination program for young girls in the United Kingdom, aimed at preventing cervical cancer, increased participation in cervical cancer screening by their mothers.
The program, introduced in the United Kingdom in 2008, provides routine vaccination for girls between 12 and 13 years of age. Families can make an informed decision to participate, being provided with necessary information on cervical cancer, the Human Papillomavirus (HPV), and the preventive role of the vaccine.
This large study examined return to cervical screening among 112,451 under-screened mothers in North West England whose daughters had been offered the vaccine at school during 2 academic years between 2008 and 2010. The results were compared with women who did not have vaccine-eligible daughters. Study author Loretta Brabin, PhD, explained, “Potentially, a lack of knowledge or understanding about the causes and risk of cervical cancer could prevent women from attending screening. We wanted to see if a daughter’s involvement in HPV vaccination stimulated her mother’s cervical screening attendance.”
The study found that mothers whose daughters had the option to be vaccinated, did get screened for the cancer more often than the comparator cohort (odds ratio (OR), 1.04; 95% confidence interval (CI), 1.02-1.07) for lapsed and OR, 1.57 (CI, 1.48-1.67) for mothers who were never screened. Further, the authors write that screening return was significantly higher in the year prior to HPV vaccination for lapsed mothers (OR, 1.06) and in the current vaccination year for lapsed (OR, 1.05) and never screened mothers (OR, 1.16).
The motivation for this dramatic change in attitude towards screening? The active discussions between mothers and their daughters on the importance of preventive vaccination. “Mothers told us that they often still have reservations about screening but discussing vaccination and screening with their daughters encouraged some to set an example by returning to the screening program,” said lead author Angela, Spencer.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More